XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue recognition and accounts receivable (Tables)
9 Months Ended
Sep. 30, 2022
Revenue Recognition And Accounts Receivable [Abstract]  
Schedule of Net Sales by Major Product Category by Reporting Segment

The table below presents net sales by major product category by reporting segment:

 

 

 

Three Months Ended September 30,

 

(U.S. Dollars, in thousands)

 

2022

 

 

2021

 

 

Change

 

Bone Growth Therapies

 

$

46,531

 

 

$

45,168

 

 

 

3.0

%

Spinal Implants

 

 

25,857

 

 

 

28,151

 

 

 

-8.1

%

Biologics

 

 

13,798

 

 

 

12,806

 

 

 

7.7

%

Global Spine

 

 

86,186

 

 

 

86,125

 

 

 

0.1

%

Global Orthopedics

 

 

27,810

 

 

 

26,303

 

 

 

5.7

%

Net sales

 

$

113,996

 

 

$

112,428

 

 

 

1.4

%

 

 

 

Nine Months Ended September 30,

 

(U.S. Dollars, in thousands)

 

2022

 

 

2021

 

 

Change

 

Bone Growth Therapies

 

$

136,244

 

 

$

137,821

 

 

 

-1.1

%

Spinal Implants

 

 

80,693

 

 

 

83,943

 

 

 

-3.9

%

Biologics

 

 

42,686

 

 

 

41,351

 

 

 

3.2

%

Global Spine

 

 

259,623

 

 

 

263,115

 

 

 

-1.3

%

Global Orthopedics

 

 

78,861

 

 

 

76,300

 

 

 

3.4

%

Net sales

 

$

338,484

 

 

$

339,415

 

 

 

-0.3

%

Schedule of Components Net Sales

The table below presents product sales and marketing service fees, which are both components of net sales:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(U.S. Dollars, in thousands)

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Product sales

 

$

100,485

 

 

$

100,004

 

 

$

296,652

 

 

$

299,214

 

Marketing service fees

 

 

13,511

 

 

 

12,424

 

 

 

41,832

 

 

 

40,201

 

Net sales

 

$

113,996

 

 

$

112,428

 

 

$

338,484

 

 

$

339,415

 

Allowances for Expected Credit Losses

The following table provides a detail of changes in the Company’s allowance for expected credit losses for the three and nine months ended September 30, 2022 and 2021:

 

(U.S. Dollars, in thousands)

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Allowance for expected credit losses beginning balance

 

$

5,589

 

 

$

4,471

 

 

$

4,944

 

 

$

4,848

 

Current period provision for expected credit losses

 

 

574

 

 

 

590

 

 

 

1,713

 

 

 

376

 

Write-offs charged against the allowance and other

 

 

10

 

 

 

(54

)

 

 

(236

)

 

 

(134

)

Effect of changes in foreign exchange rates

 

 

(225

)

 

 

(79

)

 

 

(473

)

 

 

(162

)

Allowance for expected credit losses ending balance

 

$

5,948

 

 

$

4,928

 

 

$

5,948

 

 

$

4,928

 

Schedule of Changes in Contract Liability

The following table provides a detail of changes in the Company’s contract liability associated with the Accelerated and Advanced Payment Program for the three and nine months ended September 30, 2022 and 2021:

(U.S. Dollars, in thousands)

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Contract liability beginning balance

 

$

 

 

$

10,971

 

 

$

4,791

 

 

$

13,851

 

Recoupment recognized in net sales

 

 

 

 

 

(3,071

)

 

 

(4,791

)

 

 

(5,951

)

Contract liability ending balance

 

$

 

 

$

7,900

 

 

$

 

 

$

7,900